Efficacy of topical application of beta urogastrone (recombinant human epidermal growth factor) in Wagner's Grade 1 and 2 diabetic foot ulcers: Comparative analysis of 50 patients

Journal of Natural Science, Biology and Medicine

Volumn 5, Issue 2, 2014, Pages 273-277

  Singla, Sanjeev ^a   Garg, Ramneesh ^a   Kumar, Abhishek ^b   Gill, Chiranjiv ^a  

^a DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

^b GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Diabetic foot; Growth factors; Wound healing

Indexed keywords

EID: 84904153799     PISSN: 09769668     EISSN: 22297707     Source Type: Journal    
DOI: 10.4103/0976-9668.136160     Document Type: Article

References (19)

1. Cruse PJ, Foord R. A five-year prospective study of 23,649 surgical wounds. Arch Surg 1973;107: 206-10.
2. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22: 157-62.
3. Frykberg RG. Diabetic foot ulcers: Pathogenesis and management. Am Fam Physician 2002;66: 1655-62.
4. Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care 1998;21: 1714-9.
5. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle diabetic foot study. Diabetes Care 1999;22: 1036-42.
6. Jeffcoate WJ. The incidence of amputation in diabetes. Acta Chir Belg 2005;105: 140-4.
7. Wagner FW Jr. The dysvascular foot: A system for diagnosis and treatment. Foot Ankle 1981;2: 64-122.
8. Molan PC, Betts JA. Clinical usage of honey as a wound dressing: An update. J Wound Care 2004;13: 353-6.
9. Stein MD, Salkin LM, Freedman AL, Glushko V. Collagen sponge as a topical hemostatic agent in mucogingival surgery. J Periodontol 1985;56: 35-8.
10. Han SK, Choi KJ, Kim WK. Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: A pilot study. Plast Reconstr Surg 2004;114: 1783-9.
11. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL. Growth factors in the treatment of diabetic foot ulcers. Br J Surg 2003;90: 133-46.
12. Fallon JH, Seroogy KB, Loughlin SE, Morrison RS, Bradshaw RA, Knaver DJ, et al. Epidermal growth factor immunoreactive material in the central nervous system: Location and development. Science 1984;224: 1107-9.
13. Kwon YB, Kim HW, Roh DH, Yoon SY, Baek RM, Kim JY, et al. Topical application of epidermal growth factor accelerates wound healing by myofibroblast proliferation and collagen synthesis in rat. J Vet Sci 2006;7: 105-9.
14. Zheng J, Huang XY, Wei X. A study on the promoting effects of recombinant human epidermal growth factor on skin wound healing in rats. Zhonghua Zheng Xing Wai Ke Za Zhi 2005;21: 379-83.
15. Laato M, Kähäri VM, Niinikoski J, Vuorio E. Epidermal growth factor increases collagen production in granulation tissue by stimulation of fibroblast proliferation and not by activation of procollagen genes. Biochem J 1987;247: 385-8.
16. Vishwanathan V, Pendsey S. Safety and efficacy of rhEGF in healing diabetic foot ulcers. Wounds 2006;18: 186-96.
17. Afshari M, Larijani B, Fadaei M, Pajouhi M, Bastanhagh MH, Baradar Jr. Effect of local epidermal growth factors on wound healing in diabetic foot. Iran J Endocrinol Metab 2003;5: (SN 18).
18. Brown GL, Curtsinger L, Jurkiewicz MJ, Nahai F, Schultz G. Stimulation of healing of chronic wounds by epidermal growth factor. Plast Reconstr Surg 1991;88: 189-94.
19. Tsang MW, Wong WK, Hung CS, Lai KM, Tang W, Cheung EY, et al. Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care 2003;26: 1856-61.